Venoplant

Venoplant is a phlebology product line marketed by Ceres Pharma, following its acquisition of Aesculapius Farmaceutici, designed for the management of venous disorders such as chronic venous insufficiency, hemorrhoids, and cellulite. Available in oral (tablets, sachets) and topical (cream gel) formulations, Venoplant contains a synergistic combination of botanical active ingredients, including escin from Horse Chestnut, coumarin from Sweet Clover (Melilotus), and triterpenes from Centella asiatica. These components work to improve microcirculatory tropism, enhance capillary tone, and promote lymphatic drainage, thereby reducing symptoms like swelling, heaviness, and nocturnal restlessness in the lower limbs. The oral formulations utilize the patented Enterosoma-I technology to optimize the intestinal absorption of its active constituents. Venoplant is positioned as an over-the-counter (OTC) food supplement rather than a prescription pharmaceutical.

Brand names

Venoplant

Other names

Venoplant Cream GelVenoplant TabletsVenoplant Sachets